In the final segment of this three-part series, explore how MD Financial Management and Scotiabank are working together to help Canadian physicians take their finances further at every stage of their medical career. In this third segment of the series, meet “Dr.
A recent study found the drug combination lenalidomide + rituximab is a durable, effective and safe alternative to the standard regimen combining rituximab and chemotherapy.
The treatment is approved for patients who have a moderate to high risk of recurrence, following nephrectomy or nephrectomy accompanied by surgical resection of metastatic lesions.
In the second segment of this three-part series, explore how MD Financial Management and Scotiabank are working together to help Canadian physicians take their finances further at every stage of their medical career.
In the first of a three-part series, we explore how Canadian physicians can take their finances further at every stage of their medical career. In this first segment of the series, meet “Dr. Michael Sanderson” and “Dr. Lisa Ng”.
